Oxford Asset Management’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-27,040
Closed -$113K 2194
2019
Q3
$113K Buy
+27,040
New +$113K ﹤0.01% 1623